Back to trial detailsIntake questionnaire
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
Applying to University of Pennsylvania · Philadelphia, Pennsylvania
Answer a few short questions to share with the research team.
0 of 3 answered